Description:
Delegates attending this course will benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs will be reviewed with emphasis on mode of action, dose intensity and chemotherapy regimes. The range of side effects of chemotherapy treatment – both common and uncommon – will be studied in detail. Quality of life issues in terms of overall assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumor types: breast, lung, upper
gastrointestinal (GI), colorectal, ovarian, prostate and skin cancer. Each session will be presented by clinicians active in these areas and will focus on overall patient presentation and management and cancer diagnosis and staging. Following these sessions, our experts will lead delegates in interactive group discussions on the key issues relating to effective management of each tumor types.
The limitations of cytotoxic drugs currently available are well known. With this in mind, the course
includes in-depth discussions on new drug development and identification of new pharmacological targets of particular interest and value. Clinical trials design issues will also be discussed.
Who Should Attend?
Healthcare’s courses are designed for both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Topics include:
- Cancer: Terminology and classification
- Introduction to anti-cancer drugs
- Side effects of chemotherapy and radiotherapy
- New developments in cancer therapy
- Introduction to: Breast, lung, upper GI, colorectal, ovarian, prostate and skin cancers
- Clinical trial issues in oncology
Course Instructors:
Robert Carlson, MD, Stanford University School of Medicine, Staford
Adil Daud, MD, University of California, San Francisco
Nancy A. Dawson, MD, Georgetown University Hospital, Washington
Maurie Markman, MD, MD Anderson Cancer Center, Houston
Alan Venook, MD, University of California, San Francisco
Schedule:
October 28: 8:30 am – 5:15 pm October 29: 8:00 am – 3:30 pm
Administrative Details:
The registration fee at our VIP Discount Rate is $3,415 USD (regular rate $3,790 USD). This includes lunch and refreshments throughout the day. Accommodation costs are not included. Delegates can register on-line or by completing the booking form and returning it together with the appropriate payment to Cambridge Healthtech Institute. Please retain a copy of the booking form for your records. Details of the venue will be supplied on registration.